Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929226735Aexternal-prioritypatent/GB9226735D0/en
Application filed by Zeneca LtdfiledCriticalZeneca Ltd
Publication of MX9400128ApublicationCriticalpatent/MX9400128A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a 2-(2-furil)-5-)2-(morfolino) etilamino) (1,2,4)triazol(1,5-a)-(1,3,5)-triazina-na-7-amina, y a las sales farmacéuticamente aceptables, del mismo, los cuales son selectivos de los antagonistas de adenosina A2A. También se mencionan las composiciones framacéuticas, que comprenden los compuestos y a un procedimiento para su preparación.The present invention relates to 2- (2-furyl) -5-) 2- (morpholino) ethylamino) (1,2,4) triazole (1,5-a) - (1,3,5) -triazine- na-7-amine, and to the pharmaceutically acceptable salts thereof, which are selective for adenosine A2A antagonists. Pharmaceutical compositions are also mentioned, comprising the compounds and a process for their preparation.
MX9400128A1992-12-221994-01-03
DERIVATIVES OF AZOL.
MX9400128A
(en)
Heterotricyclic derivatives, methods for their preparation and pharmaceutical compositions containing them (HETEROTRICYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM)
2- (2-N-ALCOXIFENIL) -PURIN-6-ONAS 9-SUBSTITUTED, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE TO PREPARE PHARMACEUTICAL COMPOSITIONS.